Inventor
WILSON DOUGLAS
GB55 patents
⚠️ This page may combine multiple inventors who share the name “WILSON DOUGLAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BLUEPRINT MEDICINES CORP
18 patentsUS9944651B2Apr 17, 2018
Compositions useful for treating disorders related to kit
BLUEPRINT MEDICINES CORP33 citations98
US10584114B2Mar 10, 2020
Inhibitors of RET
BLUEPRINT MEDICINES CORP13 citations94
US10030005B2Jul 24, 2018
Inhibitors of RET
BLUEPRINT MEDICINES CORP38 citations94
US9994575B2Jun 12, 2018
Compositions useful for treating disorders related to kit
BLUEPRINT MEDICINES CORP32 citations94
US9994552B2Jun 12, 2018
Compositions useful for treating disorders related to kit
BLUEPRINT MEDICINES CORP31 citations94
US9884861B2Feb 6, 2018
Compositions useful for treating disorders related to kit
BLUEPRINT MEDICINES CORP32 citations94
US10233186B2Mar 19, 2019
Inhibitors of activin receptor-like kinase
BLUEPRINT MEDICINES CORP16 citations93
US10227329B2Mar 12, 2019
Compounds useful for treating disorders related to RET
BLUEPRINT MEDICINES CORP19 citations85
US11279688B2Mar 22, 2022
Inhibitors of RET
BLUEPRINT MEDICINES CORP5 citations84
US11827642B2Nov 28, 2023
Compositions useful for treating disorders related to KIT
BLUEPRINT MEDICINES CORP2 citations73
US11970498B2Apr 30, 2024
CDK2 inhibitors
BLUEPRINT MEDICINES CORP1 citations71
US11718602B2Aug 8, 2023
EGFR inhibitors
BLUEPRINT MEDICINES CORP2 citations70
US11634422B2Apr 25, 2023
Inhibitors of activin receptor-like kinase
BLUEPRINT MEDICINES CORP1 citations70
US12545684B2Feb 10, 2026
CDK2 inhibitors
BLUEPRINT MEDICINES CORP0 citations61
US11932648B2Mar 19, 2024
CDK2 inhibitors
BLUEPRINT MEDICINES CORP1 citations61
US12595265B2Apr 7, 2026
Inhibitors of activin receptor-like kinase
BLUEPRINT MEDICINES CORP0 citations59
US12172983B2Dec 24, 2024
EGFR inhibitors
BLUEPRINT MEDICINES CORP0 citations59
US12448379B2Oct 21, 2025
Wild type kit inhibitors
BLUEPRINT MEDICINES CORP0 citations48
AVERY DENNISON CORP
3 patentsBRATTER ADAM
3 patentsSMR PATENTS SARL
3 patentsBRITISH PETROLEUM CO PLC
3 patentsHODOUS BRIAN L
2 patentsPFIZER
2 patentsUS6369075B1Apr 9, 2002
7[4′-trifluoromethyl-biphenyl-2-carbonyl)amino]-quinoline-3-carboxylic acid amides, and method of inhibiting the secretion of apolipoprotein B
PFIZER54 citations93
US6713489B2Mar 30, 2004
7-[(4′-trifluoromethyl-biphenyl-2-carbonyl)amino]-quinoline-3-carboxylic acid amides, and methods of inhibiting the secretion of apolipoprotein B
PFIZER12 citations71
WILSON DOUGLAS
2 patentsBRITISH PETROLEUM CO
2 patentsCRYOVAC INC
1 patentCIBA GEIGY CORP
1 patentDIPIETRO LUCIAN V
1 patentLEAR CORP
1 patentNEUREN PHARMACEUTICALS LTD
1 patentBEISTLE COMPANY
1 patentGENERAL ELECTRIC TECHNOLOGY GMBH
1 patentMOTHERSON INNOVATIONS CO LTD
1 patentCCL LABEL INC
1 patentPSYMETRIX LTD
1 patentBOEING CO
1 patentUK GRID SOLUTIONS LTD
1 patentShowing the top 50 of 55 patents by PatentIndex Score.